We report the formicapyridines which are structurally and biosynthetically related to the 15 pentacyclic fasamycin and formicamycin aromatic polyketides but comprise a rare pyridine 16 moiety. These new compounds are trace level metabolites formed by derailment of the major 17 biosynthetic pathway. Inspired by evolutionary logic we show that rational mutation of a 18 single gene in the biosynthetic gene cluster leads to a significant increase both in total 19 formicapyridine production and their enrichment relative to the fasamycins/formicamycins. 20
Introduction
An idealised linear biosynthetic pathway to a complex natural product can be imagined 26 proceeding through a series of intermediate structures which would exist for some finite time 27
as the pathway product accumulates. These hypothetical intermediates would exist freely in 28 solution or bound to enzymes in the case of assembly line processes, and eventually all flux 29 through the pathway would end and only the final product would exist. In reality no pathways 30 proceed in this manner as the situation is complicated by varying rates of reaction for the 31 different steps, meaning that some intermediates accumulate at significant concentrations, 32
while the inherent reactivity of other intermediates, or their ability to act as substrates for 33 housekeeping enzymes not dedicated to the pathway, means that shunt metabolites often 34 arise. Matters are further complicated by the fact that pathways are often convergent, with 35 multiple units made in parallel before assembly into the final product, for example in the 36 biosynthetic pathways to macrolide or aminoglycoside 1 antibiotics. In addition, some 37 pathways are not linear, and the final product is accessed via several routes, due to the 38 inherent substrate plasticity of the biosynthetic enzymes; well-studied examples include the 39 rapamycin and erythromycin pathways 2 . Thus, in practice, any biosynthetic pathway will lead 40 to the accumulation of a mixture comprising the final product plus varying concentrations of 41 pathway intermediates and shunt metabolites. The composition of such a mixture will vary 42 further when alternate growth conditions are used 3 . Sometimes the 'final' product of the 43 pathway cannot even be clearly discerned. 44
Such mixtures of compounds are said to comprise a series of biosynthetic congeners, and 45 their identification can provide valuable information about a biosynthetic pathway and may 46 sometimes lead to new biosynthetic understanding 4 . We recently reported the formicamycins, 47 pentacyclic polyketides produced by Streptomyces formicae KY5 isolated from the fungus-48 growing plant-ant Tetroponera penzigi (Fig. 1 ). 5 In total, sixteen congeners were isolated 49 during the initial study, including three new fasamycins, a group of compounds previously 50 reported from the heterologous expression of a clone derived from environmental DNA 6 . The 51 fasamycins are likely to be biosynthetic precursors of the formicamycins. These various 52 congeners are the product of a type II polyketide synthase (PKS) operating in conjunction 53 with a series of post-PKS modifications that include O-methylation and halogenation, plus 54 oxidative and reductive modifications. Intrigued by these compounds, which exhibit potent 55 antibacterial activity, and as part of studies to decipher their biosynthetic pathway, we 56 employed targeted metabolomics to identify further congeners that may have been missed 57 during manual analysis of culture extracts. This led us to identify the formicapyridines (1) (2) (3) (4) (5) (6) (7) (8) (9) , 58 pyridine containing polyketide alkaloids which represent additional products of the 59 are minor shunt metabolites that likely arise due to derailment of the formicamycin 70 biosynthetic pathway. Intrigued by these observations we investigated the possibility of 71 reprogramming, or evolving, the BGC such that the formicapyridines might become the 72 major products of the formicamycin BGC. Following bioinformatic and mutational analysis we 73 identified a mutant ∆forS which significantly increased the production of formicapyridines 74 while reducing the combined titre of fasamycins and formicamycins. These and other 75 mutational data lead us to the hypothesis that ForS is not a cyclase but forms part of a 76 multienzyme complex where it acts as a chaperone-like protein to aid in maintaining pathway 77 fidelity and performance. The discovery and engineering of formicapyridine biosynthesis 78 raises intriguing questions regarding the evolution of type II PKS biosynthetic pathways and 79 the origins of natural product chemical diversity. 80
81

Results
82
Metabolomics led identification of the formicapyridines. We attempted to identify new 83 biosynthetic congeners using molecular networking via the Global Natural Product Social 84
Molecular Networking (GNPS) web-platform 9 . However, the aromatic, polycyclic nature of 85 these molecules limited fragmentation and the effectiveness of GNPS. Instead, as most 86 fasamycin and formicamycin congeners are halogenated, we established a bespoke 87 dereplication method by making use of S. formicae KY5 mutants that we reported previously, 88
including an entire BGC deletion strain (for), and a strain in which the pathway specific 89 halogenase gene was deleted (forV) 5 (Fig. 2 ). Our earlier study 5 showed that the for 90 mutant does not produce any fasamycins or formicamycins, and the forV mutant produces 91 only non-halogenated fasamycin congeners. 92 characteristic halogen-containing patterns (strain ΔforV lacks a halogenase gene; Δfor lacks 96 the entire biosynthetic gene cluster). 97
Replicate (n=3) ethyl acetate extracts of the wild type (WT), for and forV strains, along 98 with equivalent extracts from uninoculated mannitol soya flour (MS) agar plates, were 99 analysed by liquid chromatography high-resolution mass spectroscopy (LC-HRMS). Using 100 the Profiling Solutions software (Shimadzu Corporation), the WT dataset (Supplementary 101 Dataset 1) was filtered to remove ions also present in the other samples. Only two other 102
BGCs in the S. formicae KY5 genome 10 contain putative halogenase encoding genes, so we 103 hypothesised that any chlorine-containing ions present in the filtered dataset would likely 104 derive from the formicamycin biosynthetic pathway. This process dramatically reduced the 105 dataset complexity, leaving less than 200 unique ions from an original set of approx. 3000. 106
Manual curation showed that most of the remaining ions corresponded to halogenated 107 molecules (based on isotope patterns), leaving twelve previously identified fasamycin and 108 formicamycin congeners, two new fasamycin/formicamycin congeners that remain 109 uncharacterized due to trace levels, and the known isoflavone 6-chlorogenistein 11 along with 110 a regioisomer (Supplementary Note 1). Analysis of C/H ratios and m/z data allowed us to 111 identify a group of three additional new metabolites (4-6) with mass spectra suggesting a 112 close structural relationship to the fasamycins/formicamycins; these varied only in the 113 number of methyl groups present. By searching for equivalent ions lacking chlorine atoms 114 we identified three additional congeners (1) (2) (3) . Compounds 1-6 were not initially observed in 115 the UV chromatograms of the WT, and qualitative examination of the LCMS data suggested 116 titres at least 100-fold lower than for the formicamycins. Furthermore, and surprisingly, the 117 m/z data implied the presence of a single nitrogen atom. 118
We then repeated the experiment but included a set of WT strain fermentations to which 119 sodium bromide (2 mM) was added, as our previous study showed this leads to the 120 biosynthesis of brominated formicamycin congeners 5 This allowed the identification of three 121 conditional bromine-containing metabolites (7-9) with MS characteristics like those of 4-6 122 ( Fig. 2 and Supplementary Figure 1 ), lending support to the hypothesis that these 123 compounds represent a family of biosynthetic congeners. 124
Isolation, structure elucidation and biological activity. HRMS data allowed us to predict 125 molecular formulae for 1-9 that were used to search the online chemical database 126 REAXYS 12 . This suggested that they represented new structures. To isolate sufficient 127 material for structure determination and antibacterial assays, the growth of S. formicae KY5 128 was scaled up (14 L; ~450 MS agar plates). After nine days incubation at 30°C the combined 129 agar was chopped up, extracted with ethyl acetate, and the solvent removed under reduced 130 pressure. The resulting extract was subjected to repeated rounds of reversed-phase HPLC 131 followed by Sephadex LH-20 size exclusion chromatography. In this way, small quantities of 132 purified 1-6 were isolated. 133
We first determined the structure of 2 which was isolated in the largest amount (~2 mg). degrees of unsaturation. The UV spectrum showed absorption maxima at 229, 249, 272 and 137 392 nm indicating a complex conjugated system that was somewhat different to that of the 138 fasamycins and formicamycins. 5 Inspection of the 13 which led to two potential substructures consisting of 26 carbon atoms, leaving one carbonyl 147 relationship with the fasamycins, we predicted the structure to be that shown for 2. We thus 149 plotted the 13 C chemical shifts for 2 against those for fasamycin C (10), the closest structural 150 congener, and then all other congeners. The data were in excellent agreement with the main 151 differences at C7, C22 and C23, consistent with the adjacent nitrogen atom (Supplementary 152 Figure 2 ). With the structure of 2 in hand we could readily assign the structures of 1 and 3-6 153 (Supplementary Note 2). NOESY correlations played a key role allowing us to link the 154 methoxy group at C3 with H2 and H4 (e.g. 2, 3, 5 and 6), and the methoxy at C5 with H4 155 (e.g. 3 and 6). We also used NOESY and HSQC correlations to distinguish C14 and C16 156 once one was chlorinated: given the NOESY correlations to the gem-dimethyl groups of C26 157 and C27 with H16, and the disappearance of a HSQC linkage for C14, we concluded that 158 C14 was chlorinated (e.g. 4-6). Compounds 1-6 exhibit optical activity with small []D 2 0 values 159 between +8° and +13°, indicating a preferred conformation about the chiral axis of the C6-160 C7 bond. However, we were unable to assign the stereochemistry due to the small amounts 161 of compound and very weak electronic circular dichroism (ECD) spectra. Due to the very low 162 levels of production, we have assigned preliminary structures for 7-9 based on 4-6, with a 163 bromine atom replacing chlorine at C14. production of the fasamycins and formicamycins, and the requirement of ForV for their 185 halogenation were described previously 5 .) 186
The very low level of formicapyridines made by the WT strain suggests they are shunt 187 metabolites arising from aberrant derailment of fasamycin/formicamycin biosynthesis. On 188 this basis, we suggest a biosynthetic pathway as described in Fig 
201
This pathway requires that C25 of the formicapyridines originates from C2 of an acetate unit, 202 with C1 lost via decarboxylation. To support our hypothesis, and the backbone structural 203 assignments, S. formicae KY5 was cultivated on MS agar plates for two days and then 204 overlaid with a solution of [1,2-13 C2] sodium acetate (1 mL of 60 mM solution; final 205 concentration 2 mM). This was repeated on the four following days, and after a total of 9 206 days incubation the agar was extracted with ethyl acetate and the most abundant congener 207 was isolated (2, ~1 mg), and the 13 C NMR spectrum was acquired. Due to the small amount 208 of material, and overlapping signals, only eight of the intact acetate units could be 209 unambiguously identified based on their coupling contests in addition to an enriched singlet 210 for C25 ( Fig. 5; Supplementary Figure 4 ). This is consistent with our biosynthetic hypothesis 211 which requires that the carbon atom at C25 derives from C2 of a fragmented acetate unit. 212
The data were in accordance with the proposed structure for 2. 213 Integration of the signal for C25 confirmed enrichment of the 13 C isotope and the absence of 217 coupling to any adjacent carbon atom. In contrast, the methyl group atom C24 shows 218 enrichment and coupling to C1. The C2 atom of [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C2] sodium acetate is highlighted as a 219 blue circle, the C1 atom as a black circle, and the coupled unit by a bold line. The gene product ForD shows significant sequence similarity to aromatase/cyclases 238 (ARO/CYC) such as the N-terminal domain (pfam 03364) of the archetypical tetracenomycin 239 polyketide cyclase TcmN which belongs to the Bet v1-like superfamily (cl10022) 15 . Extensive 240 in vivo analysis 16, 17, 18 and in vitro reconstruction 19 showed that TcmN catalyses formation of 241 the first two rings of tetracenomycin via sequential C9-C14 and C7-C16 242 cyclization/aromatization reactions. Thus, we predict ForD will play a key role in formation of 243 the rings E and D during fasamycin biosynthesis. The ForL gene product belongs to the 244 TcmI family of polyketide cyclases (cl24023; pfam 04673). The function of TcmI has also 245 been verified by in vivo mutational analysis 20 and biochemical characterisation 21 , 22 . It 246 catalyses cyclization of the final ring during formation of tetracenomycin F1 from 247 tetracenomycin F2, and this reaction is remarkably like that proposed in our hypothesis for 248 the formation of ring-B as the final step of fasamycin backbone assembly (Fig. 4) . ForR is a 249 homologue of the zinc containing polyketide cyclase RemF from the resistomycin BGC 23, 24 . 250
RemF is a single domain protein (pfam 07883) comprising the conserved barrel domain of 251 the cupin superfamily (cl21464) 25 . Finally, the gene products ForS and ForU are both single 252 domain proteins (pfam 03992) belonging to the ABM superfamily (cl10022). A notable 253 member of this family is ActVA-orf6 which functions as a monooxygenase during 254 biosynthesis of the polyketide antibiotic actinorhodin; the structure of this enzyme has been 255 solved and it is topologically related to the PKS cyclase TcmI and homologues 26 To interrogate their roles, we used Cas9-mediated genome editing 32 to make in-frame 264 deletions in each of these five putative cyclase genes (forD, forL, forR, forS and forU). Three 265 independent mutants generated from each gene deletion experiment, along with the WT 266 strain, were grown on MS agar and cultured at 30°C for nine days. To assess differences in 267 secondary metabolite production the ethyl acetate extracts from each culture were subjected 268 to HPLC(UV) and LCMS analysis (Supplementary Dataset 2). The metabolic profiles showed 269 that the forD, forL, forR and forU mutants lost the ability to produce formicapyridines, fasamycins and formicamycins ( Supplementary Figures 5-9 formicapyridines; (f) combined total fasamycins and formicamycins; (g) total fasamycins; (h) 287 total formicamycins (mean ± standard deviation; n = 3). 288
In contrast, production of formicapyridines was increased approx. 25-fold in the forS mutant 289 when compared to the WT (Fig. 6 ). These effects were complemented by ectopic expression 290 of forS under the control of the ermE* promoter. Moreover, the forS mutant was 291 significantly compromised in its ability to produce formicamycins, with their titre being 292 reduced to approximately one third that of the WT strain. This result is consistent with our 293 hypothesis for formicapyridine biosynthesis and suggests that ForS plays a role during B-294 ring closure, and that this constitutes the final step of fasamycin backbone biosynthesis. 295
However, it also demonstrates that the final cyclization step can occur reasonably efficiently 296 without ForS. While carrying out analysis of the forS mutant we also identified a new minor 297 congener which was not otherwise identified in any WT strain fermentations. Scale up 298 growth (4 L) and solvent extraction, followed by isolation (3.4 mg) and structural elucidation 299 using the approaches described above, identified this compound (13) Using targeted metabolomics, we identified a new family of pyridine containing polyketide 305 natural products that we have named the formicapyridines. Remarkably, these compounds 306 are derived from the fasamycin/formicamycin biosynthetic machinery meaning that the for 307 BGC is responsible for the production of three structurally differentiated pentacyclic scaffolds. 308
Then, inspired by evolutionary considerations, we introduced a gene deletion into the BGC 309 which significantly altered the relative levels of these metabolites in a targeted manner: the 310 titre of formicapyridines was significantly increased (approx. 25-fold) in contrast to the 311 fasamycin/formicamycins which were decreased to approx. one third of the WT titre. These 312 results raise a series of questions about the cyclization events associated with the 313 fasamycin/formicamycin biosynthetic pathway, as well as the maintenance of pathway 314
fidelity. 315
Our data suggest that formation of ring-B of the fasamycin scaffold is the final biosynthetic 316 step leading to the linear tetracyclic portion of the molecule, followed by thioester hydrolysis 317 to liberate the ACP and subsequent decarboxylation to remove the carboxyl group attached 318 to C24 (Fig. 5 ). Consistent with this, deletion of forS led to the isolation of a new shunt 319 metabolite fasamycin F (13) with a C24-carboxyl group that was not observed from the WT. 320
However, while ForS is implicated in ring-B cyclization it is not required for this role, nor, 321 apparently, for the biosynthesis of any congeners. Rather, ForS seems to decrease the 322 production of 'aberrant' congeners from the pathway, e.g. formicapyridines, while increasing 323 overall productivity. The most parsimonious interpretation of these data is that another of the 324 for BGC gene products is the actual catalyst for ring-B formation, and that ForS acts as a 325 'chaperone' which modulates or stabilises the assembly, or arrangement, of a multienzyme 326 complex to optimise production of the fasamycins, and therefore ultimately the 327 formicamycins. This has the consequence of minimising the production of shunt metabolites, 328
i.e. the formicapyridines. Thus, while deletion of forS leads to the phenotype desired from 329 our thought experiment, the mechanism by which this occurs is not what was anticipated. 330
Interpretation of the for BGC bioinformatic analysis above suggests the most likely candidate 331 for a ring-B (final) cyclase is ForL, due to its close relationship with TcmI which catalyses a 332 similar final cyclization step during tetraceomycin biosynthesis 20, 21, 22 . The apparent lack of 333 any intermediates or shunt metabolites being accumulated by the remaining mutants is 334 somewhat surprising and suggests an absolute requirement for the formation of a PKS-335 cyclase complex before biosynthesis can be initiated. 336
These observations are reminiscent of studies regarding the biosynthesis of pradimicin 33 . 337
The pradimicins are pentangular structures similar to the benastatins 27, 28 , and the BGC 338 responsible for their production contains a complement of three PKS cyclases equivalent to 339 ForD (PdmD), ForL (PdmK), and ForR (PdmL) 33, 34 It also contains two ABM domain proteins 340 (PdmH and PdmI; c.f. ForS and ForU) which were assigned monooxygenase roles. Through 341 heterologous expression of PKS gene cassettes it was deduced that for the biosynthetic 342 pathway to function correctly, and yield a pentangular backbone, all three cyclase genes 343 (PdmDKL) plus the ABM domain monooxygenase PdmH must be co-expressed. It should be 344 noted that in this pathway an oxidation reaction to form the quinone structure is required. 345
These results led the authors to propose a model in which the two cyclases PdmKL and the 346 monooxygenase PdmH form a multienzyme complex that engulfs the entire polyketide 347 molecule during its assembly and work synergistically to ensure the correct reaction pathway 348 occurs thereby minimising the production of shunt metabolites 33 . Similarly, formation of the 349 unusual discoid metabolite resistomycin involves an extremely rare S-shaped folding pattern 350 and requires the coordinated function, likely as a multienzyme complex, of core PKS 351 proteins in addition to three distinct cyclase enzymes 24 . Moreover, heterologous 352 reconstruction of the resistomycin pathway gave no products when the minimal PKS plus 353 first cyclase were assembled 24 , a rare observation that is in keeping with our data showing 354 the requirement of all the putative cyclases ForDLRU to produce any pathway derived 355 metabolites, including shunts. 356
During biosynthesis of the for BCG polyketide backbones there is no requirement for 357 the function of a monooxygenase. Consistent with this, deletion of forS does not abolish 358 polyketide production, but instead affects pathway productivity and fidelity. Thus, based on 359 our mutational data, and the observations discussed above, we hypothesise that ABM family 360 enzymes can act as monooxygenases and/or as ancillary proteins to tune, in some way, the 361 PKS enzyme complex function, and therefore the biosynthetic pathway, during aromatic 362 polyketide biosynthesis. Genes encoding these proteins occur commonly in PKS BGCs, and 363 multiple paralogues are often present, even when monooxygenase reactions are not 364 required. It is noteworthy that several PKS cyclases occur as fusion proteins with an ABM 365 domain, which can be located at either terminus. We speculate, tentatively, that these may 366 represent examples of mature pathways where the chaperone-like function of the ABM 367 family protein has become essential, leading to selective pressure for the encoding gene to 368 become transcriptionally fused with other cyclase encoding genes. 369
Materials & Methods
370
Chemistry methods and materials. Unless stated otherwise all chemicals were supplied by 371
Sigma-Aldrich or Fisher Scientific. [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C2] sodium acetate was purchased from 372 CORTECNET. All solvents were of HPLC grade or equivalent. NMR spectra were recorded 373 on a Bruker Avance III 400 MHz NMR spectrometer equipped with 5 mm BBFO Plus probe 374 unless noted otherwise. The 13 C NMR spectra for 2 and isotopically enriched 2 after feeding 375 Standard microbiology and molecular biology methods. All strains used or made in this 392 study are described in Supplementary Table 1 . All plasmids and ePACs used are described 393
in Supplementary Table 2 . All PCR primers used are described in Supplementary Table 3 . 394
The composition of media used are described in Supplementary Table 4 . The antibiotics and 395 their concentrations used are described in Supplementary Table 5 . Standard DNA 396 sequencing was carried out by Eurofins Genomics using the Mix2Seq kit (Ebersberg, 397 Germany). 398 E. coli strains were cultivated at 37°C in LB Lennox Broth (LB), shaking at 220 rpm, or LB 399 agar supplemented with antibiotics as appropriate. S. formicae was cultivated at 30°C on 400 mannitol soya flour (MS) agar or MYM agar with appropriate antibiotic selection. To prepare 401
Streptomyces spores, material from a single colony was plated out using a sterile cotton bud 402 and incubated at 30°C for 7-10 days until a confluent lawn had grown over the entire surface 403 of the agar. Spores were harvested by applying 20% glycerol (2 mL) to the surface of the 404 agar plate culture and gently removing spores with a sterile cotton bud before storing them 405 at -80°C. Glycerol stocks of E. coli were made by pelleting the cells from an overnight E. coli 406 culture (3-5 mL) in a bench top centrifuge (5000 rpm, 5 min) and resuspending in fresh, 407 sterile 1:1 2YT/40% glycerol (1 mL). Glycerol stocks were stored at -80˚C. plates for colony count in triplicate following Miles and Misra protocol 35 . 434
Generating mutant strains of S. formicae. CRISPR/Cas9 genome editing was conducted 435 as described previously using the pCRISPomyces-2 plasmid supplied by Addgene 1,2 . 436 Protospacers to use in the synthetic guide RNA (sgRNA) were annealed by heating to 95°C 437 for 5 min followed by ramping to 4°C at 0.1°C/sec. Annealed protospacers were assembled 438 into the pCRISPomyces-2 backbone at the BbsI site by Golden Gate assembly as described previously 5 . The two homology repair template arms (each approx. 1kb) were assembled 440 into the plasmid containing the sgRNA at the XbaI site using Gibson Assembly as described 441 previously 5 . Genetic complementation was achieved using either the native promoter or the 442 constitutive, high-level ermE* promoter and single copies of the relevant gene(s) cloned into 443 the integrative vector pMS82, as described previously 5 . Gibson assembly was used to fuse 444 the gene(s) (and the native promoter if located distally in the BGC) and assemble them into 445 the chosen plasmid. Plasmids were confirmed by PCR amplification and sequencing. 446
Plasmids were then conjugated into S. formicae KY5 via the non-methylating E. coli strain 447 ET12567 containing pUZ8002, as described previously 5, 36 . Ex-conjugants were selected on 448 the appropriate antibiotics and plasmids were cured from S. formicae using temperature 449 selection at 37°C. samples were finally purified by Sephadex LH20 size exclusion chromatography with 100% 468 methanol as the mobile phase. The isolated yields were: 1 (1 mg), 2 (2 mg), 3 (2 mg), 4 (0.7 469 mg), 5 (1 mg) and 6 (0.6 mg). These pure compounds were subjected to analysis by HRMS 470 and 1D and 2D NMR as described in the main text (see Figs 1 and 2 ). Spectroscopic and 471 other data for each compound is presented in Supplementary Note 2. 
